382 related articles for article (PubMed ID: 34314737)
1. Public health effects of travel-related policies on the COVID-19 pandemic: A mixed-methods systematic review.
Bou-Karroum L; Khabsa J; Jabbour M; Hilal N; Haidar Z; Abi Khalil P; Khalek RA; Assaf J; Honein-AbouHaidar G; Samra CA; Hneiny L; Al-Awlaqi S; Hanefeld J; El-Jardali F; Akl EA; El Bcheraoui C
J Infect; 2021 Oct; 83(4):413-423. PubMed ID: 34314737
[TBL] [Abstract][Full Text] [Related]
2. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
[TBL] [Abstract][Full Text] [Related]
3. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
[TBL] [Abstract][Full Text] [Related]
4. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Ledinger D; Zachariah C; Gartlehner G
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013574. PubMed ID: 33959956
[TBL] [Abstract][Full Text] [Related]
5. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Unintended health and societal consequences of international travel measures during the COVID-19 pandemic: a scoping review.
Klinger C; Burns J; Movsisyan A; Biallas R; Norris SL; Rabe JE; Stratil JM; Voss S; Wabnitz K; Rehfuess EA; Verboom B;
J Travel Med; 2021 Oct; 28(7):. PubMed ID: 34369562
[TBL] [Abstract][Full Text] [Related]
8. How does globalization affect COVID-19 responses?
Bickley SJ; Chan HF; Skali A; Stadelmann D; Torgler B
Global Health; 2021 May; 17(1):57. PubMed ID: 34016146
[TBL] [Abstract][Full Text] [Related]
9. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.
Stratil JM; Biallas RL; Burns J; Arnold L; Geffert K; Kunzler AM; Monsef I; Stadelmaier J; Wabnitz K; Litwin T; Kreutz C; Boger AH; Lindner S; Verboom B; Voss S; Movsisyan A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD015085. PubMed ID: 34523727
[TBL] [Abstract][Full Text] [Related]
10. Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
Kratzer S; Pfadenhauer LM; Biallas RL; Featherstone R; Klinger C; Movsisyan A; Rabe JE; Stadelmaier J; Rehfuess E; Wabnitz K; Verboom B
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015397. PubMed ID: 35661990
[TBL] [Abstract][Full Text] [Related]
11. Modelling the effect of travel-related policies on disease control in a meta-population structure.
Xu J; Wang Z; Moghadas SM
J Math Biol; 2023 Sep; 87(4):55. PubMed ID: 37688625
[TBL] [Abstract][Full Text] [Related]
12. Sufficient COVID-19 quarantine and testing on international travelers to forestall cross-border transmission after China's removal of the zero-COVID policy in early 2023.
Bojja D; Zuo S; Townsend JP
Int J Infect Dis; 2024 Aug; 145():107097. PubMed ID: 38750721
[TBL] [Abstract][Full Text] [Related]
13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
14. Sustainable border control policy in the COVID-19 pandemic: A math modeling study.
Zhu Z; Weber E; Strohsal T; Serhan D
Travel Med Infect Dis; 2021; 41():102044. PubMed ID: 33838318
[TBL] [Abstract][Full Text] [Related]
15. Global border restrictions in 2020-2021: Adherence and the effectiveness in long-term COVID-19 epidemic control.
Li Z; Yang B; Wang J; Wen Y; Xu J; Ling L; Wang T
Travel Med Infect Dis; 2023; 52():102556. PubMed ID: 36805032
[TBL] [Abstract][Full Text] [Related]
16. Cost benefit analysis of alternative testing and quarantine policies for travelers for infection control: A case study of Singapore during the COVID-19 pandemic.
Lou J; Lim NW; Cai CGX; Dickens BSL; Huynh VA; Wee HL
Front Public Health; 2023; 11():1101986. PubMed ID: 36908469
[TBL] [Abstract][Full Text] [Related]
17. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
18. Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing.
Johansson MA; Wolford H; Paul P; Diaz PS; Chen TH; Brown CM; Cetron MS; Alvarado-Ramy F
BMC Med; 2021 Apr; 19(1):94. PubMed ID: 33849546
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
20. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures.
Ryu S; Gao H; Wong JY; Shiu EYC; Xiao J; Fong MW; Cowling BJ
Emerg Infect Dis; 2020 May; 26(5):961-966. PubMed ID: 32027587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
